| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 通化金马药业集团股份有限公司成立于1990年，注册资本9.66亿，总资产47亿（股票代码000766），是全国最早上市的一批医药企业之一。金马药业集团，拥有“通化金马药业、哈尔滨圣泰制药、成都永康制药、河南源首药业”四家生产基地，拥有“长春华洋、北京民康百草、上海诗健”三家新药研究所，是集研发、生产、销售为一体的现代化制药企业集团。 哈尔滨圣泰生物制药有限公司，成立于1996年，位于黑龙江省哈尔滨市，拥有中药提取车间、生化提取车间、水针车间、冻干粉针车间、输液口服液车间、检验中心和动物实验中心等。多年来成功开发53个品种、75个品规，品种适应症涵盖心脑血管、清热解毒、儿科专用、骨科专用等治疗领域。曾被中华全国工商业联合会医药业商会评为《中国医药工业百强企业》，黑龙江省全省工业企业纳税50强，黑龙江省医药产业龙头企业。 成都永康制药有限公司位于四川省成都市温江区，是一家集生产、销售、特种养殖、科研为一体的，致力于多元化发展的中药龙头企业。公司拥有五家子公司：四川永康绿苑动物养殖有限公司、四川九寨沟中致绿苑养殖有限公司、资阳康胜养殖有限公司、成都蹑景仓储有限公司和四川金马永康麝香中医药研究有限公司。现有片剂、胶囊剂、丸剂、颗粒剂等多种剂型的传统中药为主导的生产线，40多个品种涵盖肿瘤、心脑血管、消化系统、疼痛、清热解毒等治疗领域。年生产能力：胶囊2亿粒，片剂5亿片，颗粒剂500吨，丸剂300吨。其中，拳头产品“小金丸”、“天然麝香小金丸”（国家林业局批准在全国范围允许使用天然麝香的品种之一）以其处方经典、剂型先进、疗效确切等优势，在治疗乳腺增生、甲状腺、良性肿瘤等领域独占鳌头，以良好的美誉度和品牌影响力创造了极高的市场占有率。 安阳源首药业位于中国文字的发源地、甲骨文的故乡——古都安阳，也是《周易》发源地，《殷墟》为世界文化遗产，世界最大的青铜器——司母戊大方鼎在这里出土。源首药业是一家集科研、生产、销售、教学为一体的现代化生物制药企业，为河南省高新技术企业，国家级火炬计划项目，安阳市绿色企业，五星级诚信企业。公司主导产品有蜡样芽孢杆菌活菌胶囊，蜡样芽孢杆菌活菌片，是由蜡样芽孢杆菌经发酵、收集、制成的新一代生物制品微生态活菌制剂，1997年获卫生部批准上市，是应用于临床最早的微生态制剂之一。该产品主要用于肠炎、腹泻、婴幼儿腹泻、肠功能紊乱的治疗。对治疗各种原因引起的慢性肠炎、结肠炎、秋季轮状病毒所致的腹泻效果显著；对于手术、烧伤、癌症放化疗、长期大量使用化学药品、抗生素引起的肠道菌群失调具有良好的治疗作用；对于肝炎、肝硬化，患者腹胀、消化不良、食欲不振等症状有明显的效果。 通化金马制药基地是上市公司的注册地，设有药品生产、发酵、机修等15个车间及16条生产线。可满足企业9个剂型和108个品规的生产需要，其中独家品种15个，其中进入国家乙级医保5个。主导品种包括复方嗜酸乳杆菌片，风湿祛痛胶囊，清肝健脾、仙藜口服液等。国家级创新药品琥珀八氢氨吖啶片，用于治疗阿尔兹海默病，被列为国家化学原创1.1类新药，属专利药物，处于国际领先地位。目前，化药合成车间已经建设完成，三期临床正在收尾。预计2022年下半年揭盲，年末向国家申报注册。同时，我们正在研究开发国际市场，计划前期投资15亿元，引入国际知名的风投公司，进行全球市场布局。 金马药业集团在以张玉富董事长为管理核心的坚强领导下，坚定落实“整顿、改革、发展”三步走战略，全体员工积极践行“全心立己、全力利企、利己！”这一新企业精神。按照“保稳定、谋发展、促发展”核心主题；做到“得其时，当其位”，珍惜平台，建设平台，发展平台，秉承十四五规划健康中国战略，全体同仁紧紧围绕在以张玉富董事长为核心的管理团队周围，按照董事长统一战略部署，聚力凝心，奋勇争先，为中国医药健康事业、为人民群众健康福祉不懈努力。 | ||||||||||||||||||||||||
| Main Business | 主要从事医药产品的研发、生产与销售 | ||||||||||||||||||||||||
| Legal Representative | 张玉富 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 贾伟林 | ||||||||||||||||||||||||
| Solicitors | 北京金诚同达律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0435-3910232 | ||||||||||||||||||||||||
| Fax No | 0435-3910232 | ||||||||||||||||||||||||
| Website | www.thjm.cn | ||||||||||||||||||||||||
| thjmjt@163.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 30/04/1997 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.050 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.398 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 15.195B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |